BRPI0921428A2 - composição de vacina, métodos para elicitar uma resposta imune a influenza tipo a, e para realizar vacinação em aves domésticas, e, uso de uma sialidase bacteriana - Google Patents

composição de vacina, métodos para elicitar uma resposta imune a influenza tipo a, e para realizar vacinação em aves domésticas, e, uso de uma sialidase bacteriana

Info

Publication number
BRPI0921428A2
BRPI0921428A2 BRPI0921428A BRPI0921428A BRPI0921428A2 BR PI0921428 A2 BRPI0921428 A2 BR PI0921428A2 BR PI0921428 A BRPI0921428 A BR PI0921428A BR PI0921428 A BRPI0921428 A BR PI0921428A BR PI0921428 A2 BRPI0921428 A2 BR PI0921428A2
Authority
BR
Brazil
Prior art keywords
eliciting
poultry
carrying
methods
immune response
Prior art date
Application number
BRPI0921428A
Other languages
English (en)
Inventor
Eric Edward Worrall
Original Assignee
Anhydro Biolog Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0820404A external-priority patent/GB0820404D0/en
Priority claimed from GB0900943A external-priority patent/GB0900943D0/en
Application filed by Anhydro Biolog Ltd filed Critical Anhydro Biolog Ltd
Publication of BRPI0921428A2 publication Critical patent/BRPI0921428A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/108—Orthomyxoviridae (F), e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1282—Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0921428A 2008-11-07 2009-11-03 composição de vacina, métodos para elicitar uma resposta imune a influenza tipo a, e para realizar vacinação em aves domésticas, e, uso de uma sialidase bacteriana BRPI0921428A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0820404A GB0820404D0 (en) 2008-11-07 2008-11-07 Vaccine compositions
GB0900943A GB0900943D0 (en) 2009-01-21 2009-01-21 Vaccine compositions
PCT/GB2009/051480 WO2010052492A1 (en) 2008-11-07 2009-11-03 Vaccine compositions

Publications (1)

Publication Number Publication Date
BRPI0921428A2 true BRPI0921428A2 (pt) 2016-01-05

Family

ID=41665133

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0921428A BRPI0921428A2 (pt) 2008-11-07 2009-11-03 composição de vacina, métodos para elicitar uma resposta imune a influenza tipo a, e para realizar vacinação em aves domésticas, e, uso de uma sialidase bacteriana

Country Status (7)

Country Link
US (1) US20120128716A1 (pt)
EP (1) EP2356143A1 (pt)
JP (1) JP2012508221A (pt)
CN (1) CN102203134A (pt)
BR (1) BRPI0921428A2 (pt)
MX (1) MX2011004840A (pt)
WO (1) WO2010052492A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201101950D0 (en) 2011-02-04 2011-03-23 Anhydro Ltd Vaccine compositions
MX390928B (es) * 2014-01-24 2025-03-19 Pneumagen Ltd Compuestos inmunomoduladores.
CN105342982B (zh) * 2015-11-19 2018-08-28 上海现代药物制剂工程研究中心有限公司 经鼻给药的流感疫苗免疫制剂及其制备方法
GB201616007D0 (en) * 2016-09-20 2016-11-02 Univ Court Of The Univ Of St Andrews The Novel Adjuvants
GB201616009D0 (en) 2016-09-20 2016-11-02 Univ Court Of The Univ Of St Andrews The Treatment and/or prevention of sepsis
GB201616006D0 (en) 2016-09-20 2016-11-02 Univ Court Of The Univ Of St Andrews The Cell modulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2506526C (en) * 2002-11-22 2017-04-18 Mang Yu Broad spectrum anti-viral therapeutics and prophylaxis
CN101070347B (zh) * 2006-05-12 2010-06-30 青岛宝麦德生物医药科技有限公司 禽流感h5n1新型粘膜免疫疫苗及其应用

Also Published As

Publication number Publication date
WO2010052492A1 (en) 2010-05-14
CN102203134A (zh) 2011-09-28
US20120128716A1 (en) 2012-05-24
MX2011004840A (es) 2011-08-08
EP2356143A1 (en) 2011-08-17
JP2012508221A (ja) 2012-04-05

Similar Documents

Publication Publication Date Title
BR112012019757A2 (pt) composição imunogênica, e, método para induzir uma resposta imune a um polissacarídeo capsular
BRPI1012811A2 (pt) vacinas contra o vírus herpes simplex tipo 2: composições e métodos para obtenção de uma resposta imune
BRPI0905725A2 (pt) vacina, embalagem farmacêutica e processo para criar uma resposta imune em tecido de indivíduo
BRPI0920283A2 (pt) composição e método para induzir resposta imunológica humoral
BRPI0920282A2 (pt) composição e método para induzir resposta imunológica humoral
HUE039747T2 (hu) Eljárások és kompozíciók EGFRVIII-ra való immunválasz indukálására
BR112013020070A2 (pt) moléculas de ácido nucleico que codificam novos antígenos de herpes, vacina compreendendo as mesmas e métodos de uso das mesmas
IL248607A (en) Methods and compositions for immunization against virus
DK2998315T4 (da) Newcastle sygdomsvirus-bårne fuglevacciner
SI2569009T1 (sl) Himere OSPA in njihova uporaba v cepivih
BRPI0921428A2 (pt) composição de vacina, métodos para elicitar uma resposta imune a influenza tipo a, e para realizar vacinação em aves domésticas, e, uso de uma sialidase bacteriana
EP2429585A4 (en) VACCINE IMMUNOTHERAPY
LT2437753T (lt) Sintetiniai gliukopiranozillipidų adjuvantai ir juos turinčios vakcinų kompozicijos
DK2099479T3 (da) Salmonella-vaccine i fjerkræ
PL2629794T3 (pl) Szczepionka wektorowa z herpeswirusem indyków przeciwko grypie ptaków u drobiu
PT2575873E (pt) Concentração de antigénios de vacinas com liofilização
EP2346523A4 (en) MULTICOMPONENT VACCINE AGAINST MALARIA INDUCING SUSTAINABLE IMMUNE RESPONSES AGAINST PLASMODIUM
BR112014009887A2 (pt) vacinmas e métodos para desenvolvimento de vacina para indução de imunidade a todos os sorotipos de virus da dengue
BRPI1007721A2 (pt) composição de vacina para induzir uma resposta imunológica contra um rotavírus em um indivíduo, cepa de rotavírus isolada e método para induzir uma resposta imunológica para um rotavírus em um indivíduo
PT2575872T (pt) Concentração de antigénios da vacina da gripe sem liofilização
BRPI0919485A2 (pt) vacinas, antígenos, composições de plasmodium e métodos
PT2579901T (pt) Vacina e métodos para reduzir infeção por campylobacter
PT2658570T (pt) Composições e métodos vacinais contra o vírus da diarreia viral bovina tipo 1b
BRPI0918226A2 (pt) composição imunogênica, método para produzir uma composição imunogênica, método para elicitar uma resposta imune contra neisseria, uso da composição imunogênica, e, vacina
BRPI0820258A2 (pt) composto, composições de vacina e farmacêutica, e , métodos para estimular uma resposta imune em um indivíduo e para tratar um indivíduo

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]